| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/08/2004 | WO2004029229A2 Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands |
| 04/08/2004 | WO2004029221A2 Microfluidic device for cell separation and uses thereof |
| 04/08/2004 | WO2004029217A2 Method for screening molecular interactions |
| 04/08/2004 | WO2004029093A2 Humanized anti-granulocyte mn-3 antibody and uses thereof |
| 04/08/2004 | WO2004029077A2 Method for producing acylated peptides |
| 04/08/2004 | WO2004029072A2 PrPsc -INTERACTING MOLECULES AND USES THEREOF |
| 04/08/2004 | WO2004029023A2 Cell-surface estrogen receptor and related compositions and methods |
| 04/08/2004 | WO2004028692A2 Supporting element for conducting diagnostic tests |
| 04/08/2004 | WO2004028566A1 Pharmaceutical composition for prevention and treatment of kidney diseases |
| 04/08/2004 | WO2004028559A1 Anti-angiogenic fragments of pigment epithelium-derived factor (pedf) |
| 04/08/2004 | WO2004028558A1 Preventives/remedies for neurodegenerative disease |
| 04/08/2004 | WO2004028554A2 Skrp, astray, string, vacm associated with metabolic control |
| 04/08/2004 | WO2004028551A1 Novel agents that modulate eph receptor activity |
| 04/08/2004 | WO2004028479A2 Nouvelles compositions et methodes de traitement du psoriasis |
| 04/08/2004 | WO2004028478A2 Functional mutations in respiratory syncytial virus |
| 04/08/2004 | WO2004028464A2 Methods and compositions for modification of splicing of pre-mrna |
| 04/08/2004 | WO2004028444A2 Parathyroid hormone antagonists and uses thereof |
| 04/08/2004 | WO2004028352A2 Methods for prediction and prognosis of cancer, and monitoring cancer therapy |
| 04/08/2004 | WO2004028346A2 Detection methods |
| 04/08/2004 | WO2004019039A3 Method and kit for performing functional tests on biological cells immobilized on an array of scavenger molecules |
| 04/08/2004 | WO2004014540A9 Color coated layer-by-layer microcapsules serving as combinatory analysis libraries and as specific optical sensors |
| 04/08/2004 | WO2004013607A3 Methods, devices and kits for multiplex blotting of biological samples from multi-well plates |
| 04/08/2004 | WO2004013172A3 Fragments of beta-amyloid as targets for vaccination against alzheimer disease |
| 04/08/2004 | WO2004012658A3 Method and device for protein delivery into cells |
| 04/08/2004 | WO2004011637A3 Modified adamts4 molecules and method of use thereof |
| 04/08/2004 | WO2004011401A3 Method for making biochips |
| 04/08/2004 | WO2004010537A3 Flexible biochip |
| 04/08/2004 | WO2004010109A3 Mobile analyzing device |
| 04/08/2004 | WO2004009497A3 Method of monitoring biofouling in membrane separation systems |
| 04/08/2004 | WO2004008144A3 Method capable of being automated for detection of prpres and uses thereof |
| 04/08/2004 | WO2004008135A3 Method for online measurement of molten phases |
| 04/08/2004 | WO2004007702A3 Modulators of chloride intracellular channel 1 protein signaling ____________________________________________________________ |
| 04/08/2004 | WO2004007692A3 Methods and compositions for analyzing polymers using chimeric tags |
| 04/08/2004 | WO2004006985A3 Assaying and imaging system identifying traits of biological specimens |
| 04/08/2004 | WO2004006840A3 Three dimensional cell patterned bioploymer scaffolds and method of making the same |
| 04/08/2004 | WO2004005932A3 Serological diagnostic method |
| 04/08/2004 | WO2004004643A3 Interferon gamma in the detection and treatment of angiomyolipomas |
| 04/08/2004 | WO2004001069A3 Compositions and methods for detecting pathologies affecting neuromuscular transmission |
| 04/08/2004 | WO2004001004A3 Membrane associated tumor endothelium markers |
| 04/08/2004 | WO2004000096A3 Novel bartonella antigen lysate extracts for use in elisa diagnostic |
| 04/08/2004 | WO2003106431A3 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 04/08/2004 | WO2003104764A3 Automated immunoassay cassette, apparatus and mehtod |
| 04/08/2004 | WO2003104490A3 Method for the simultaneous detection of hybridization and vaccination reactions |
| 04/08/2004 | WO2003103709A3 Cd200-receptor mediated modulation of bone development |
| 04/08/2004 | WO2003102585A3 Biomolecular kinetics method using a flow-through microarray |
| 04/08/2004 | WO2003102578B1 High throughput cellular response assay using microarrays |
| 04/08/2004 | WO2003101392A3 Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods |
| 04/08/2004 | WO2003100433A3 Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 3 (avpr3) |
| 04/08/2004 | WO2003100428A3 Method for diagnosing a tumor in a patient by determining pibf |
| 04/08/2004 | WO2003100379A3 Methods and reagents for removing contaminants from biomolecules |
| 04/08/2004 | WO2003100087A3 Regulation of novel human asparagine-hydroxylases |
| 04/08/2004 | WO2003097088A3 Methods to detect, isolate, target and manipulate hiv-infected t cells |
| 04/08/2004 | WO2003095976A3 Qm-7 and qt-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells |
| 04/08/2004 | WO2003095941A3 System and method for controlling tube thickness with ultrasound |
| 04/08/2004 | WO2003091701A3 Implantable biosensor from stratified nanostructured membranes |
| 04/08/2004 | WO2003091687A3 Method and compound for detecting traces of blood |
| 04/08/2004 | WO2003091273A3 Protein interaction system for multisubunit complexes |
| 04/08/2004 | WO2003090771A3 Diagnostics and therapeutics for diseases associated with trace amine receptor 3(ta3) |
| 04/08/2004 | WO2003083135A3 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2) |
| 04/08/2004 | WO2003080857A3 Pna oligomers, oligomers sets, methods and kits pertaining to the detection of bacillus anthracis |
| 04/08/2004 | WO2003079028A8 Automatic crucible and sample loading system and method |
| 04/08/2004 | WO2003076947A3 Method for monitoring collagen type ii degradation in cartilage |
| 04/08/2004 | WO2003076942A3 Method for the characterisation of circulating tumour cells stemming from solid cancers |
| 04/08/2004 | WO2003076610A3 Variants of human kallikrein-2 and kallikrein-3 and uses thereof |
| 04/08/2004 | WO2003076585A3 Controlled modulation of amino acid side chain length of peptide antigens |
| 04/08/2004 | WO2003072820A3 Method and nucleic acids for the analysis of colon cell proliferative disorders |
| 04/08/2004 | WO2003070974A3 Mismatch repair detection |
| 04/08/2004 | WO2003069308A3 Method of determining an analyte concentration in a sample from an absorption spectrum |
| 04/08/2004 | WO2003068921A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/08/2004 | WO2003066077A3 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 04/08/2004 | WO2003065006A3 Methods and compositions for treating cancer |
| 04/08/2004 | WO2003064468A3 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof |
| 04/08/2004 | WO2003063893A3 Fgfr agonists |
| 04/08/2004 | WO2003056336A3 Improved structured-functional bonding matrices for biomolecules |
| 04/08/2004 | WO2003056334A3 Characterisation method for functionalised surfaces |
| 04/08/2004 | WO2003053791B1 Apparatus and method for monitoring environment within a container |
| 04/08/2004 | WO2003046581A3 Methods for diagnosis and treatment of epithelial-derived cancers,such as colorectal cancers and kidney cancers |
| 04/08/2004 | WO2003042694B1 Characterization of molecules |
| 04/08/2004 | WO2003020978B1 Method for manufacturing hydrogel biochip by using star-like polyethylene glycol derivative having epoxy group |
| 04/08/2004 | WO2003017817A3 Diagnosis, prevention and treatment of cancer |
| 04/08/2004 | WO2003017177A3 Method and system for profiling biological systems |
| 04/08/2004 | WO2003016894A3 Coplanar waveguide biosensor for detecting molecular or cellular events |
| 04/08/2004 | WO2003014739A8 Method and device for integrated biomolecular analyses |
| 04/08/2004 | WO2003014382A8 Device for analyzing nucleic acid |
| 04/08/2004 | WO2003014300A3 TRPS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 04/08/2004 | WO2002099074A8 Slc7s as modifiers of the p53 pathway and methods of use |
| 04/08/2004 | WO2002097058A3 Genetic markers for improved disease resistance in animals (nramp1) |
| 04/08/2004 | WO2002095355B1 Electrochemical method for high-throughput screening of minute quantities of candidate compounds |
| 04/08/2004 | WO2002090528A9 Soft tissue devices and methods of use |
| 04/08/2004 | WO2002086082A3 Isolation of neural stem cells using gangliosides and other surface markers |
| 04/08/2004 | WO2002083854A3 Antibodies to vla-1 |
| 04/08/2004 | WO2002073154A3 Method and the detection of bacteria and bacterial groups |
| 04/08/2004 | WO2002072541A3 Human grk7: new member of the human g-protein-coupled-receptor kinase family |
| 04/08/2004 | WO2002061661A3 Methods for determining protein and peptide terminal sequences |
| 04/08/2004 | WO2002058546A3 Methods for screening for substances which inhibit fp prostanoid receptor |
| 04/08/2004 | WO2002054082A8 Use of a pure allergen component |
| 04/08/2004 | WO2002053712A9 Avian hepatitis e virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis e |
| 04/08/2004 | WO2002048402A3 Methods and compositions for generation of multiple copies of nucleic acid sequences and methods of detection thereof |
| 04/08/2004 | WO2002044319A3 Spatially directed ejection of cells from a carrier fluid |
| 04/08/2004 | WO2002029104A8 Tumor marker and methods of use |